Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial Carbohydrate-Binding Modules (CBMs) and Glycoside Hydrolases (GHs) are essential components of the carbohydrate-active enzyme (CAZyme) apparatus used by bacteria to process complex sugars. Glycoside Hydrolases are enzymes responsible for the hydrolysis of glycosidic bonds, while CBMs are non-catalytic protein domains that increase catalytic efficiency by anchoring the enzyme to its carbohydrate substrate (Boraston et al., 2004). These proteins play a pivotal role in bacterial physiology, including nutrient acquisition, cell wall synthesis, and the formation of biofilms that protect bacteria from environmental stress and host immune responses (Davies & Henrissat, 1995). In clinical contexts, these molecules are significant targets for treating infections caused by pathogens such as Streptococcus pneumoniae and Pseudomonas aeruginosa, which utilize GHs to degrade host mucus and tissues (Koropatkin et al., 2012). Therapeutic interventions include the use of small-molecule inhibitors, such as iminosugars, which mimic the transition state of carbohydrate hydrolysis to block enzyme activity. Additionally, recombinant GHs are being explored as biofilm-dispersing agents that can break down the protective polysaccharide matrix of chronic infections, thereby enhancing the penetration and efficacy of standard antibiotics (Lombard et al., 2014).
Competitive inhibition of the catalytic active site of glycoside hydrolases or disruption of substrate binding via CBM interference.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Carbohydrate-Binding Modules and Glycoside Hydrolases (CBMs and GHs).